Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation.
Turesson I.
Radiother Oncol. 1990 Sep;19(1):1-15. doi: 10.1016/0167-8140(90)90161-o.
Pulsed low dose-rate radiotherapy: radiobiology and dosimetry.
Ma CMC.
Phys Med Biol. 2022 Jan 28;67(3). doi: 10.1088/1361-6560/ac4c2f.
Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: equivalent regimens for combined brachytherapy and external irradiation.
Brenner DJ, Huang Y, Hall EJ.
Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1415-23. doi: 10.1016/0360-3016(91)90315-u.
Estimation of repair parameters in mouse lip mucosa during continuous and fractionated low dose-rate irradiation.
Stüben G, Landuyt W, van der Schueren E, van der Kogel AJ, Reijnders A.
Radiother Oncol. 1991 Jan;20(1):38-45. doi: 10.1016/0167-8140(91)90110-3.
Good Timing Matters: The Spatially Fractionated High Dose Rate Boost Should Come First.
Schültke E, Jaekel F, Bartzsch S, Bräuer-Krisch E, Requardt H, Laissue JA, Blattmann H, Hildebrandt G.
Cancers (Basel). 2022 Dec 2;14(23):5964. doi: 10.3390/cancers14235964.
Low-dose rate irradiation.
Hall EJ, Marchese M, Rubin J, Zaider M.
Front Radiat Ther Oncol. 1988;22:19-29.
Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids.
Omura M, Torigoe S, Kurihara H, Matsubara S, Kubota N.
Acta Oncol. 1998;37(7-8):681-6. doi: 10.1080/028418698430043.
[Radiobiology in brachytherapy].
Hennequin C, Mazeron JJ.
Cancer Radiother. 2013 Apr;17(2):81-4. doi: 10.1016/j.canrad.2013.03.001. Epub 2013 Apr 4.
A comparison between low dose rate radiotherapy and conventionally fractionated irradiation in moderately extensive cancers of the oropharynx.
Pierquin B, Calitchi E, Mazeron JJ, Le Bourgeois JP, Leung S.
Int J Radiat Oncol Biol Phys. 1985 Mar;11(3):431-9. doi: 10.1016/0360-3016(85)90172-5.
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update.
Hudson JM, Loblaw A, McGuffin M, Chung HT, Tseng CL, Helou J, Cheung P, Szumacher E, Liu S, Zhang L, Deabreu A, Mamedov A, Morton G.
Radiother Oncol. 2024 Sep;198:110381. doi: 10.1016/j.radonc.2024.110381. Epub 2024 Jun 13.
